Merck's new bone drug appears to work, according to a clinical trial of the osteoporosis treatment that was stopped early tonight, although investors will have to wait to see full results of the study. Full results won't be available for some time. But the news that an independent data safety and [...]
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Has Merck Found The Heir To Fosamax?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account